batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Japan endorses the way of Datroway 27 December 2024 A new pivotal Nectin-4 player 23 December 2024 Third time lucky for Mesoblast 19 December 2024 FDA knocks back subcutaneous Rybrevant 17 December 2024 Checkpoint's latecomer could draw interest 16 December 2024 Foghorn goes quiet on non-selective project 16 December 2024 BeiGene is next into MAT2A inhibition 13 December 2024 ASH 2024 – the BTK degraders are neck and neck 11 December 2024 Load More